Alcohol consumption produces acetaldehyde, a toxic compound that damages DNA. Scientists from IOCB Prague reveal how cells repair this damage, shedding light on the link between alcohol and cancer.

IOCB Prague is co-founding Taveren Therapeutics, a new biotech spin-off developing a novel cancer treatment strategy based on reactivating the body’s natural tumor suppressors.

Researchers at IOCB Prague developed a highly precise and ultra-stable fluorescent labeling method that stays attached even inside cells, enabling long-term, reliable tracking of biomolecules.

Dr. Petr Cígler receives the Rudolf Lukeš Prize 2025 for groundbreaking lipid and diamond nanoparticles that advance gene therapy, cancer treatment, imaging, and modern vaccine development.

IOCB Prague scientists have developed light-driven molecular motors that remain fully functional even when anchored to metal surfaces, marking a major step toward controllable nanoscale machines.

IOCB Prague scientists led by Dr. Petr Cígler developed a method to create quantum nanodiamonds within minutes—over 1,000× faster than before, paving the way for affordable large-scale nanosensor production.

The Czech PROTOCELL experiment from IOCB Prague will study protocell formation on the ISS to explore whether life could originate beyond Earth.

Scientists at IOCB Prague created MSⁿLib, a vast mass spectrometry library with millions of records, enabling rapid unknown compound identification and boosting drug discovery and biomedical AI.

Researchers at IOCB Prague developed a simple and universal late-stage iodine-125 labeling method for peptides and proteins, enabling faster, cheaper, and high-quality production for drug discovery.

Chemists at IOCB Prague developed a fast, robust SNAr-based method to synthesize drug-like atropisomers, unlocking access to hindered C–N bonds with practical and mild conditions.